ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,748,379 | +11.0% | 2,723,011 | +14.4% | 5.08% | -23.5% |
| Q2 2023 | $8,782,200 | -7.6% | 2,380,000 | -17.1% | 6.65% | +26.1% |
| Q1 2023 | $9,499,700 | -14.7% | 2,870,000 | 0.0% | 5.27% | -6.8% |
| Q4 2022 | $11,135,600 | +58.9% | 2,870,000 | -0.5% | 5.66% | +120.3% |
| Q3 2022 | $7,007,000 | -11.5% | 2,883,710 | -27.9% | 2.57% | -18.9% |
| Q2 2022 | $7,920,000 | +31.1% | 4,000,000 | +21.2% | 3.17% | +56.8% |
| Q1 2022 | $6,039,000 | +29.8% | 3,300,000 | 0.0% | 2.02% | +57.5% |
| Q4 2021 | $4,653,000 | – | 3,300,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |